{"date":"2025-11-07","count":66,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-8403-2025-11-07-2341-1c7bp6i","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"23:41:20","subject":"公告本公司董事會決議設置提名委員會","clause":"第6款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-11-07 23:41，「公告本公司董事會決議設置提名委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-11-07-2256-kgg624","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-07","time":"22:56:00","subject":"公告本公司114年第一次現金增資認股基準日等相關事宜(更正員工認股數字)","clause":"第9款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-11-07 22:56，「公告本公司114年第一次現金增資認股基準日等相關事宜(更正員工認股數字)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-11-07-2132-1gi7sc9","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"21:32:15","subject":"公告本公司董事會決議通過召開114年第二次股東臨時會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-11-07 21:32，「公告本公司董事會決議通過召開114年第二次股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-11-07-2129-1ns63uj","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"21:29:00","subject":"公告本公司董事會決議辦理私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-11-07 21:29，「公告本公司董事會決議辦理私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-11-07-2126-apdf62","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"21:26:24","subject":"本公司民國114年度第三季合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-11-07 21:26，「本公司民國114年度第三季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-11-07-1906-14868dp","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"19:06:32","subject":"公告本公司背書保證達公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款","clause":"第22款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-11-07 19:06，「公告本公司背書保證達公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-11-07-1904-tupb3s","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"19:04:48","subject":"代子公司嘉文麗(福建)化妝品有限公司公告新增資金貸與金額達處理準則第22條第一項第三款","clause":"第23款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-11-07 19:04，「代子公司嘉文麗(福建)化妝品有限公司公告新增資金貸與金額達處理準則第22條第一項第三款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-11-07-1901-1uhskx3","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"19:01:33","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第11款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-11-07 19:01，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-11-07-1900-zvlmnp","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"19:00:29","subject":"公告本公司董事會解除經理人競業禁止之限制","clause":"第21款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-11-07 19:00，「公告本公司董事會解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-11-07-1859-1qytcve","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"18:59:38","subject":"公告本公司董事會通過對關係人捐贈事宜","clause":"第43款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-11-07 18:59，「公告本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-11-07-1859-1egfkms","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"18:59:08","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-11-07 18:59，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-11-07-1858-1xfuutk","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"18:58:37","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-11-07 18:58，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-11-07-1858-129cimm","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"18:58:23","subject":"公告本公司董事會通過114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-11-07 18:58，「公告本公司董事會通過114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2025-11-07-1822-n7ntx3","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"18:22:46","subject":"公告本公司民國114年度第三季合併財務報告業經提報董事會","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2025-11-07 18:22，「公告本公司民國114年度第三季合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-11-07-1738-1h5ao62","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"17:38:14","subject":"本公司董事會決議通過本公司114年度第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-11-07 17:38，「本公司董事會決議通過本公司114年度第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-11-07-1731-aqrptb","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"17:31:53","subject":"公告本公司董事會通過114年第3季財務報表","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-11-07 17:31，「公告本公司董事會通過114年第3季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-11-07-1731-129cimm","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"17:31:10","subject":"公告本公司董事會通過114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-11-07 17:31，「公告本公司董事會通過114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-11-07-1727-1qytcve","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"17:27:09","subject":"公告本公司董事會通過對關係人捐贈事宜","clause":"第43款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-11-07 17:27，「公告本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-11-07-1721-zaw2nq","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"17:21:44","subject":"代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形","clause":"第51款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-11-07 17:21，「代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-11-07-1721-o57xk6","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"17:21:22","subject":"公告董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-11-07 17:21，「公告董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-11-07-1721-1ogcyvd","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"17:21:01","subject":"公告本公司向關係人取得不動產使用權資產","clause":"第20款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-11-07 17:21，「公告本公司向關係人取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2025-11-07-1714-15mmvem","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"17:14:37","subject":"公告本公司董事會通過114年度第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2025-11-07 17:14，「公告本公司董事會通過114年度第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-11-07-1712-sn40ae","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"17:12:22","subject":"公告本公司資安主管異動","clause":"第8款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-11-07 17:12，「公告本公司資安主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-11-07-1708-146fcv5","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"17:08:31","subject":"公告本公司聘任投資暨永續長","clause":"第8款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-11-07 17:08，「公告本公司聘任投資暨永續長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-11-07-1704-1xfuutk","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"17:04:22","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-11-07 17:04，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-11-07-1700-dkcrfq","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"17:00:30","subject":"更正本公司114年10月份為他人背書保證明細表","clause":"第51款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-11-07 17:00，「更正本公司114年10月份為他人背書保證明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-11-07-1659-1bl6dwx","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"16:59:13","subject":"更正本公司114年10月份資金貸與他人明細表","clause":"第51款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-11-07 16:59，「更正本公司114年10月份資金貸與他人明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-11-07-1653-1io03lx","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:53:23","subject":"公告本公司董事會通過對財團法人佳醫健康基金會(關係人)捐贈事宜","clause":"第43款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-11-07 16:53，「公告本公司董事會通過對財團法人佳醫健康基金會(關係人)捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-11-07-1651-1syllvn","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:51:47","subject":"公告本公司董事會決議設置第一屆永續發展委員會暨委任永續發展委員會委員","clause":"第6款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-11-07 16:51，「公告本公司董事會決議設置第一屆永續發展委員會暨委任永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-11-07-1651-129cimm","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:51:31","subject":"公告本公司董事會通過114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-11-07 16:51，「公告本公司董事會通過114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-11-07-1651-1r3vm6d","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:51:01","subject":"公告本公司董事會通過114年度第三季財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-11-07 16:51，「公告本公司董事會通過114年度第三季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-11-07-1648-am8bf","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-07","time":"16:48:29","subject":"公告本公司114年第一次現金增資認股基準日等相關事宜","clause":"第9款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-11-07 16:48，「公告本公司114年第一次現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2025-11-07-1644-16aetnz","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"16:44:36","subject":"公告本公司114年第三季財務合併報告提報董事會。","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2025-11-07 16:44，「公告本公司114年第三季財務合併報告提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-11-07-1640-t3ut9u","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:40:07","subject":"公告本公司董事會決議114年第3季股利發放","clause":"第14款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-11-07 16:40，「公告本公司董事會決議114年第3季股利發放」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-11-07-1639-u4bht2","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:39:49","subject":"公告本公司董事會通過民國114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-11-07 16:39，「公告本公司董事會通過民國114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-11-07-1619-19zuud8","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-11-07","time":"16:19:55","subject":"訊聯細胞智藥研發之臍帶血幹細胞外泌體產品，獲美國個人護理產品協會(PCPC)審查通過，核發國際化妝品原料(INCI name)","clause":"第44款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-11-07 16:19，「訊聯細胞智藥研發之臍帶血幹細胞外泌體產品，獲美國個人護理產品協會(PCPC)審查通過，核發國際化妝品原料(INCI na」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-11-07-1619-1c7bp6i","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:19:06","subject":"公告本公司董事會決議設置提名委員會","clause":"第6款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-11-07 16:19，「公告本公司董事會決議設置提名委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-11-07-1618-10qn6yl","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"16:18:26","subject":"公告本公司更換股務代理機構案經集保公司准予備查","clause":"第51款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-11-07 16:18，「公告本公司更換股務代理機構案經集保公司准予備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-11-07-1618-hcclaf","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:18:23","subject":"代重要子公司優品生醫股份有限公司公告決議盈餘分配案","clause":"第14款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-11-07 16:18，「代重要子公司優品生醫股份有限公司公告決議盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-11-07-1617-1xfuutk","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:17:56","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-11-07 16:17，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2025-11-07-1617-1lp8kam","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2025-11-07","time":"16:17:18","subject":"公告本公司細胞中心GTP實驗室之細胞製備場所，依據「特定醫療技術檢查檢驗醫療儀器施行或使用管理辦法」申請細胞製備場所認可案，獲衛福部函覆認可(認可編號:TP108C003)-18","clause":"第44款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2025-11-07 16:17，「公告本公司細胞中心GTP實驗室之細胞製備場所，依據「特定醫療技術檢查檢驗醫療儀器施行或使用管理辦法」申請細胞製備場所認可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-11-07-1613-1a6rac9","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-11-07","time":"16:13:12","subject":"本公司擬調整現金增資發行價格","clause":"第9款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-11-07 16:13，「本公司擬調整現金增資發行價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-11-07-1612-1u6pvow","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:12:26","subject":"公告本公司取得經濟部產業發展署出具「係屬科技事業且具市場性」之意見書","clause":"第44款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-11-07 16:12，「公告本公司取得經濟部產業發展署出具「係屬科技事業且具市場性」之意見書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-11-07-1605-11i0cv","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"16:05:26","subject":"公告本公司董事會通過114年度第3季財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-11-07 16:05，「公告本公司董事會通過114年度第3季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2025-11-07-1553-1uhskx3","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2025-11-07","time":"15:53:05","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2025-11-07 15:53，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-11-07-1549-1ev1paf","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:49:14","subject":"本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第11款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-11-07 15:49，「本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-11-07-1543-129cimm","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:43:06","subject":"公告本公司董事會通過114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-11-07 15:43，「公告本公司董事會通過114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-11-07-1542-5dyb62","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:42:29","subject":"公告本公司董事會決議114年第3季虧損撥補暨114年第3季不發放股利","clause":"第14款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-11-07 15:42，「公告本公司董事會決議114年第3季虧損撥補暨114年第3季不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-11-07-1541-129cimm","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"15:41:26","subject":"公告本公司董事會通過114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-11-07 15:41，「公告本公司董事會通過114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-11-07-1540-8aem5q","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"15:40:55","subject":"依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款公告","clause":"第22款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-11-07 15:40，「依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-11-07-1540-1gxwwo1","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:40:35","subject":"本公司因會計師事務所內部輪調政策更換簽證會計師","clause":"第7款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-11-07 15:40，「本公司因會計師事務所內部輪調政策更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-11-07-1540-puuep8","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"15:40:24","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告","clause":"第23款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-11-07 15:40，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-11-07-1540-cypi6g","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:40:08","subject":"本公司董事會決議辦理註銷庫藏股並訂定減資基準日","clause":"第11款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-11-07 15:40，「本公司董事會決議辦理註銷庫藏股並訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-11-07-1539-1tixvya","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:39:46","subject":"本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-11-07 15:39，「本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-11-07-1539-i3gvx","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:39:12","subject":"本公司董事會決議處分不動產","clause":"第51款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-11-07 15:39，「本公司董事會決議處分不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-11-07-1523-1xfuutk","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:23:37","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-11-07 15:23，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2025-11-07-1522-1xfuutk","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"15:22:18","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2025-11-07 15:22，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-11-07-1505-kxgk3x","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:05:34","subject":"公告本公司發言人及代理發言人異動","clause":"第8款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-11-07 15:05，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-11-07-1503-1xfuutk","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"15:03:28","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-11-07 15:03，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-11-07-1502-1ckd4vq","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"15:02:50","subject":"公告本公司董事會決議通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-11-07 15:02，「公告本公司董事會決議通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2025-11-07-1501-1xfuutk","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:01:43","subject":"公告本公司董事會通過114年第三季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2025-11-07 15:01，「公告本公司董事會通過114年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2025-11-07-1501-129cimm","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"15:01:23","subject":"公告本公司董事會通過114年第3季合併財務報告","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2025-11-07 15:01，「公告本公司董事會通過114年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2025-11-07-1445-1rl2c71","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-11-07","time":"14:45:06","subject":"公告本公司114年第3季合併財務報告業經提報董事會通過","clause":"第31款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-11-07 14:45，「公告本公司114年第3季合併財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-11-07-1423-1ye5yun","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-11-07","time":"14:23:28","subject":"公告本公司114年第二次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-11-07 14:23，「公告本公司114年第二次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2025-11-07-1351-p67uuk","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2025-11-07","time":"13:51:50","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2025-11-07 13:51，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-11-07-0905-8jz32o","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-11-07","time":"09:05:57","subject":"公告本公司114年度現金增資股款催繳事宜","clause":"第44款","fact_date":"2025-11-07","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-11-07 09:05，「公告本公司114年度現金增資股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}